14-Methoxydihydromorphinone
 | |
| Names | |
|---|---|
| IUPAC name
(5α)-3-Hydroxy-14-methoxy-17-methyl-4,5-epoxymorphinan-6-one | |
| Identifiers | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 24675846 |
| |
| |
| Properties | |
| C18H21NO4 | |
| Molar mass | 315.37 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
14-Methoxydihydromorphinone is a semi-synthetic opioid related to 14-methoxymetopon (14-MM), an opioid with a Ki of 0.15 nM, and 14-O-methyloxymorphone (14-OMO) with a Ki of 0.10 nM. By contrast, oxymorphone has a Ki of 0.97 nM and morphine one of 6.55 nM (all at mu receptors). This suggests that both 14-OMO and 14-MM have a higher mu/kappa selectivity than oxymorphone.[1][2]
See also
References
- ↑ Spetea, M; Bohotin, CR; Asim, MF; Stübegger, K; Schmidhammer, H (2010). "In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function". Eur J Pharm Sci. 41 (1): 125–135. doi:10.1016/j.ejps.2010.05.018. PMC 2954314
. PMID 20600882. - ↑ Schmidhammer, H; Spetea, M (2011). "Synthesis of 14-alkoxymorphinan derivatives and their pharmacological actions". Top Curr Chem. 299: 63–91. PMID 21630508.
| Opioids | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paracetamol-type |
| ||||||||||||||||||||||||||||||
| NSAIDs |
| ||||||||||||||||||||||||||||||
| Cannabinoids | |||||||||||||||||||||||||||||||
| Ion channel modulators |
| ||||||||||||||||||||||||||||||
| Myorelaxants | |||||||||||||||||||||||||||||||
| Others | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the 7/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.